GenMark Diagnostics (GNMK) Misses Q1 EPS by 2c

GenMark Diagnostics (NASDAQ: GNMK) reported Q1 EPS of ($0.30), $0.02 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $12.45 million.

GUIDANCE:

GenMark Diagnostics sees FY2017 revenue of $65-70 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49